EP3129006
IMMUNOSUPPRESSANT FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.4.2015EP published:
27.1.2021EP application number:
15735733.6
EPO information:
European Patent Register
Max expiry date:
7.4.2035
Title:
IMMUNOSUPPRESSANT FORMULATION
Timeline
Today
8.4.2015EP application
27.1.2021EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
BOUILLOT, Philippe Michel ReneAddress:
4002 Basel, CH
Name:
REYNAUD, EmericAddress:
4002 Basel, CH
Priority
Number:
201461977806 PDate:
10.4.2014Country:
US
Classification
Categories:
A61K 9/16, A61K 9/20, A61K 9/28, A61K 31/397